Results 241 to 250 of about 80,978 (300)

Ultrasound-Based Skeletal Muscle Assessment for Prognostication in Cirrhosis: A Systematic Review. [PDF]

Liver Int
Cola SD, Gallo P, Gazda J, Khan S, Lapenna L, Gioia S, Nardelli S, Vespasiani-Gentilucci U, Merli M.   +8 more
europepmc   +1 more source

Surgical-Orthodontic Treatment of a Severe Hyperdivergent Skeletal Class III Malocclusion With Dento-Alveolar Compensations: A Case Report. [PDF]

Cureus
Drissi Lahsini M, Loudini N, Zaoui F, Halimi A.   +3 more
europepmc   +1 more source

Rethinking sustained recompensation in MASLD cirrhosis: The value of pharmacological maintenance. [PDF]

Hepatol Commun
Toshikuni N, Shimatani M.
europepmc   +1 more source

Editorial: Diabetes Management in Cirrhosis-The Window of Opportunity Before Decompensation. [PDF]

Aliment Pharmacol Ther
Pramotedham T, Tan YC.
europepmc   +1 more source

A Case Series of Sudden Death in Children Aged 12 Months to 4 Years From LPIN1 Deficiency and PPA2 Deficiency in Queensland

Journal of Paediatrics and Child Health, EarlyView.
Sophie Manoy, Sally Smith, Marita Smith, Catherine Atthow, Janette Spicer, Matthew Lynch, Michelle Lipke, Julie A. McEniery, David Coman, Anita Inwood, Jim McGill, Carolyn Bursle   +11 more
wiley   +1 more source

[Decompensation].

Ugeskrift for laeger, 1998
Fluid and sodium retention with peripheral oedema and ascites are often seen in decompensated patients with diseases of the liver, kidney and heart and in malignancies. Despite a careful clinical examination including relevant biochemical tests, decompensation is associated with diagnostic challenges.
S, Møller, J H, Henriksen
core   +3 more sources

Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis [PDF]

Journal of Hepatology, 2022
Whether non-selective β-blockers can prevent decompensation of cirrhosis needs clarification. Carvedilol might be particularly effective since its intrinsic vasodilatory activity may ameliorate hepatic vascular resistance, a major mechanism of portal ...
Càndid Villanueva, Ferran Torres, Edilmar Alvarado-Tapias   +2 more
exaly   +3 more sources

Hepatic Decompensation in Cirrhotic Patients Receiving Antiviral Therapy for Chronic Hepatitis B

Clinical Gastroenterology and Hepatology, 2021
Objectives: It is unclear if anti-hepatitis B virus (HBV) treatment can eliminate incident hepatic decompensation. Here we report the incidence and predictors of hepatic decompensation among cirrhotic patients receiving antiviral therapy for chronic ...
Jun Yong Park, Hye Won Lee, Terry Cheuk-Fung Yip   +2 more
exaly   +2 more sources